Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. more
Time Frame | CCEL | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.52% | 0.31% | -1.26% |
1-Month Return | -7.04% | 0.6% | -4.16% |
3-Month Return | 22.31% | -9.44% | -0.46% |
6-Month Return | 3.93% | -5.15% | 3.58% |
1-Year Return | 31.21% | 0.33% | 22.47% |
3-Year Return | -35.37% | 4.53% | 25.13% |
5-Year Return | -0.67% | 35.98% | 77.7% |
10-Year Return | 208.85% | 100.72% | 190.12% |
Nov '19 | Nov '20 | Nov '21 | Nov '22 | Nov '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 31.82M | 31.15M | 28.88M | 30.34M | 31.34M | [{"date":"2019-11-30","value":100,"profit":true},{"date":"2020-11-30","value":97.9,"profit":true},{"date":"2021-11-30","value":90.79,"profit":true},{"date":"2022-11-30","value":95.35,"profit":true},{"date":"2023-11-30","value":98.51,"profit":true}] |
Cost of Revenue | 10.04M | 9.66M | 8.99M | 8.79M | 8.44M | [{"date":"2019-11-30","value":100,"profit":true},{"date":"2020-11-30","value":96.23,"profit":true},{"date":"2021-11-30","value":89.57,"profit":true},{"date":"2022-11-30","value":87.61,"profit":true},{"date":"2023-11-30","value":84.12,"profit":true}] |
Gross Profit | 21.78M | 21.49M | 19.90M | 21.54M | 22.90M | [{"date":"2019-11-30","value":95.11,"profit":true},{"date":"2020-11-30","value":93.84,"profit":true},{"date":"2021-11-30","value":86.87,"profit":true},{"date":"2022-11-30","value":94.07,"profit":true},{"date":"2023-11-30","value":100,"profit":true}] |
Gross Margin | 68.46% | 68.99% | 68.88% | 71.02% | 73.07% | [{"date":"2019-11-30","value":93.69,"profit":true},{"date":"2020-11-30","value":94.43,"profit":true},{"date":"2021-11-30","value":94.27,"profit":true},{"date":"2022-11-30","value":97.2,"profit":true},{"date":"2023-11-30","value":100,"profit":true}] |
Operating Expenses | 15.13M | 14.48M | 15.51M | 17.08M | 35.21M | [{"date":"2019-11-30","value":42.97,"profit":true},{"date":"2020-11-30","value":41.14,"profit":true},{"date":"2021-11-30","value":44.06,"profit":true},{"date":"2022-11-30","value":48.53,"profit":true},{"date":"2023-11-30","value":100,"profit":true}] |
Operating Income | 5.06M | 7.66M | 4.00M | 4.02M | (12.30M) | [{"date":"2019-11-30","value":66.08,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":52.25,"profit":true},{"date":"2022-11-30","value":52.53,"profit":true},{"date":"2023-11-30","value":-160.59,"profit":false}] |
Total Non-Operating Income/Expense | (3.37M) | (4.17M) | (2.79M) | (2.23M) | (2.30M) | [{"date":"2019-11-30","value":-337473700,"profit":false},{"date":"2020-11-30","value":-416629100,"profit":false},{"date":"2021-11-30","value":-278592800,"profit":false},{"date":"2022-11-30","value":-222728600,"profit":false},{"date":"2023-11-30","value":-229725700,"profit":false}] |
Pre-Tax Income | 3.39M | 5.04M | 2.61M | 3.32M | (13.36M) | [{"date":"2019-11-30","value":67.3,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":51.82,"profit":true},{"date":"2022-11-30","value":65.86,"profit":true},{"date":"2023-11-30","value":-265.2,"profit":false}] |
Income Taxes | 1.10M | 1.41M | 527.71K | 547.54K | (3.84M) | [{"date":"2019-11-30","value":77.8,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":37.3,"profit":true},{"date":"2022-11-30","value":38.7,"profit":true},{"date":"2023-11-30","value":-271.63,"profit":false}] |
Income After Taxes | 2.29M | 3.62M | 2.08M | 2.77M | (9.52M) | [{"date":"2019-11-30","value":63.2,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":57.48,"profit":true},{"date":"2022-11-30","value":76.46,"profit":true},{"date":"2023-11-30","value":-262.7,"profit":false}] |
Income From Continuous Operations | 2.29M | 3.62M | 2.08M | 2.77M | (9.52M) | [{"date":"2019-11-30","value":63.2,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":57.48,"profit":true},{"date":"2022-11-30","value":76.46,"profit":true},{"date":"2023-11-30","value":-262.7,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-11-30","value":"-","profit":true},{"date":"2020-11-30","value":"-","profit":true},{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":"-","profit":true},{"date":"2023-11-30","value":"-","profit":true}] |
Net Income | 2.29M | 3.62M | 2.08M | 2.77M | (9.52M) | [{"date":"2019-11-30","value":63.2,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":57.48,"profit":true},{"date":"2022-11-30","value":76.46,"profit":true},{"date":"2023-11-30","value":-262.7,"profit":false}] |
EPS (Diluted) | (0.69) | 0.45 | 0.25 | 0.34 | (1.14) | [{"date":"2019-11-30","value":-153.33,"profit":false},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":55.56,"profit":true},{"date":"2022-11-30","value":75.56,"profit":true},{"date":"2023-11-30","value":-253.33,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CCEL | |
---|---|
Cash Ratio | 0.12 |
Current Ratio | 0.61 |
Quick Ratio | 0.57 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CCEL | |
---|---|
ROA (LTM) | -0.13% |
ROE (LTM) | 129.20% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CCEL | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.15 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.15 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CCEL | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.87 |
P/B | 9.72 |
Price/FCF | 28 |
EV/R | 2.14 |
EV/Ebitda | NM |
PEG | NM |
CryoCell International Inc (CCEL) share price today is $7.4
Yes, Indians can buy shares of CryoCell International Inc (CCEL) on Vested. To buy CryoCell International Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CCEL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of CryoCell International Inc (CCEL) via the Vested app. You can start investing in CryoCell International Inc (CCEL) with a minimum investment of $1.
You can invest in shares of CryoCell International Inc (CCEL) via Vested in three simple steps:
The 52-week high price of CryoCell International Inc (CCEL) is $9.23. The 52-week low price of CryoCell International Inc (CCEL) is $4.35.
The price-to-earnings (P/E) ratio of CryoCell International Inc (CCEL) is
The price-to-book (P/B) ratio of CryoCell International Inc (CCEL) is 9.72
The dividend yield of CryoCell International Inc (CCEL) is 13.79%
The market capitalization of CryoCell International Inc (CCEL) is $59.66M
The stock symbol (or ticker) of CryoCell International Inc is CCEL